Form 483

Avioq, Inc. Form 483, 2023-12-05

FDA issued a Form 483 to Avioq, Inc. on 2023-12-05 with 3 public-safe observations.

483· Form 483 issuedBiologics3 observations

Avioq, Inc. · Durham, United States · Issued December 5, 2023

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

5 Dec 2023
21 CFR 820.150

Lack of or inadequate procedures for storage.

Cited by Gene D Arcy, Priscilla M Pastrana, Edward A Brunt

5 Dec 2023
21 CFR 820.184

DHR - not or inadequately maintained

Cited by Gene D Arcy, Priscilla M Pastrana, Edward A Brunt

5 Dec 2023
21 CFR 820.60

Identification procedures, Lack of or inadequate procedures

Cited by Gene D Arcy, Priscilla M Pastrana, Edward A Brunt

Inspected site

AIAvioq, Inc.Durham, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.150Cited across public-safe Form 483 observations1x
21 CFR 820.184Cited across public-safe Form 483 observations1x
21 CFR 820.60Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere